Treatment and Prevention of Depression

• Published in: Psychological science in the public interest Vol. 3; no. 2; pp. 39 - 77
• Main Authors: Hollon, Steven D., Thase, Michael E., Markowitz, John C.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA Blackwell Publishers 01.11.2002; SAGE Publications; SAGE PUBLICATIONS, INC
• Subjects: Antidepressants; Archives; Bipolar disorder; Chronic mental disorders; Clinical medicine; Clinical psychology; Cognition; Cognition & reasoning; Cognitive therapy; Combination therapy; Delayed; Depression; Depressive disorders; Disease management; Efficacy; Family therapy; Illness; Interpersonal conflict; Interpersonal psychotherapy; Intervention; Lithium; Major depressive disorder; Medical treatment; Medications; Mental depression; Mental health; Pharmacology; Placebos; Psychiatry; Psychological distress; Psychology; Psychotherapy; Recurrence; Recurrent; Relapse; Risk reduction; Soft skills
• ISSN: 1529-1006; 2160-0031; 1539-6053
• DOI: 10.1111/1529-1006.00008

Depression is one of the most common and debilitating psychiatric disorders and is a leading cause of suicide. Most people who become depressed will have multiple episodes, and some depressions are chronic. Persons with bipolar disorder will also have manic or hypomanic episodes. Given the recurrent nature of the disorder, it is important not just to treat the acute episode, but also to protect against its return and the onset of subsequent episodes. Several types of interventions have been shown to be efficacious in treating depression. The antidepressant medications are relatively safe and work for many patients, but there is no evidence that they reduce risk of recurrence once their use is terminated. The different medication classes are roughly comparable in efficacy, although some are easier to tolerate than are others. About half of all patients will respond to a givenmedication, and many of those who do not will respond to some other agent or to a combination of medications. Electroconvulsive therapy is particularly effective for the most severe and resistant depressions, but raises concerns about possible deleterious effects on memory and cognition. It is rarely used until a number of different medications have been tried. Although it is still unclear whether traditional psychodynamic approaches are effective in treating depression, interpersonal psychotherapy (IPT) has fared well in controlled comparisons with medications and other types of psychotherapies. It also appears to have a delayed effect that improves the quality of social relationships and interpersonal skills. It has been shown to reduce acute distress and to prevent relapse and recurrence so long as it is continued or maintained. Treatment combining IPT with medication retains the quick results of pharmacotherapy and the greater interpersonal breadth of IPT, as well as boosting response in patients who are otherwise more difficult to treat. The main problem is that IPT has only recently entered clinical practice and is not widely available to those in need. Cognitive behavior therapy (CBT) also appears to be efficacious in treating depression, and recent studies suggest that it can work for even severe depressions in the hands of experienced therapists. Not only can CBT relieve acute distress, but it also appears to reduce risk for the return of symptoms as long as it is continued or maintained. Moreover, it appears to have an enduring effect that reduces risk for relapse or recurrence long after treatment is over. Combined treatment with medication and CBT appears to be as efficacious as treatment with medication alone and to retain the enduring effects of CBT. There also are indications that the same strategies used to reduce risk in psychiatric patients following successful treatment can be used to prevent the initial onset of depression in persons at risk. More purely behavioral interventions have been studied less than the cognitive therapies, but have performed well in recent trials and exhibit many ofthe benefits of cognitive therapy. Mood stabilizers like lithium or the anticonvulsants form the core treatment for bipolar disorder, but there is a growing recognition that the outcomes produced by modern pharmacology are not sufficient. Both IPT and CBT show promise as adjuncts to medication with such patients. The same is true for family-focused therapy, which is designed to reduce interpersonal conflict in the family. Clearly, more needs to be done with respect to treatment of the bipolar disorders. Good medical management of depression can be hard to find, and the empirically supported psychotherapies are still not widely practiced. As a consequence, many patients do nothave access to adequate treatment. Moreover, not everyone responds to the existing interventions, and not enough is known about what to do for people who are not helped by treatment. Although great strides have been made over the past few decades, much remains to be done with respect to the treatment of depression and the bipolar disorders.